Evidence map›Paper›PMID 38660521›Full record

ArticleExperimental and therapeutic medicine2024

An asymptomatic male individual carrying a 5.72 Mb

Christina Keramida, Ioannis Papoulidis, Efterpi Pappa, Thomas Liehr, Konstantinos Kalmantis, Angeliki Gerede, Efterpi Pavlidou, Michael Bjorn Petersen, Emmanouil Manolakos

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental and therapeutic medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Christina KeramidaAccess to Genome P.C., Clinical Laboratory Genetics, 11527 Athens, Greece.
Ioannis PapoulidisAccess to Genome P.C., Clinical Laboratory Genetics, 11527 Athens, Greece.
Efterpi PappaAccess to Genome P.C., Clinical Laboratory Genetics, 11527 Athens, Greece.
Thomas LiehrUniversity Hospital, Friedrich Schiller University, Institute of Human Genetics, D-07747 Jena, Germany.
Konstantinos KalmantisDepartment of Obstetric and Gynecological Ultrasound, IASO Maternity Hospital, 15123 Athens, Greece.
Angeliki GeredeDepartment of Obstetrics and Gynecology, Maternal-Fetal Medicine, Democritus University of Thrace, 69100 Alexandroupolis, Greece.
Efterpi PavlidouDepartment of Speech and Language Therapy, University of Ioannina, 45110 Ioannina, Greece.
Michael Bjorn PetersenAccess to Genome P.C., Clinical Laboratory Genetics, 11527 Athens, Greece.
Emmanouil ManolakosAccess to Genome P.C., Clinical Laboratory Genetics, 11527 Athens, Greece.
Democritus University of Thrace · GRFriedrich Schiller University Jena · DELETO Maternity Hospital · GRUniversity of Ioannina · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Numerous rearrangements in the 8p23 chromosomal region have been reported; included in these rearrangements are isolated deletions in this area. Such deletions are associated with a wide range of phenotypic characteristics, including motor impairment, epilepsy, intellectual disability, cardiac defects and seizures. The present study describes the case of a 30-year-old asymptomatic man that carries a

Indexed as

8p23Array Comparative Genomic Hybridizationcytogeneticsdeletionfluorescence in situ hybridizationkaryotype

Identifiers

PMID38660521
PMCPMC11040221
OpenAlexW4393850194

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.